Jefferies Financial Group Inc. Increases Stock Position in The Cooper Companies, Inc. $COO

Jefferies Financial Group Inc. raised its holdings in The Cooper Companies, Inc. (NASDAQ:COO) by 177.2% during the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 59,877 shares of the medical device company’s stock after purchasing an additional 38,277 shares during the period. Jefferies Financial Group Inc.’s holdings in Cooper Companies were worth $4,908,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of COO. Bell Investment Advisors Inc raised its position in shares of Cooper Companies by 106.3% in the third quarter. Bell Investment Advisors Inc now owns 425 shares of the medical device company’s stock valued at $29,000 after buying an additional 219 shares during the last quarter. CYBER HORNET ETFs LLC acquired a new position in shares of Cooper Companies in the second quarter valued at approximately $36,000. True Wealth Design LLC raised its position in shares of Cooper Companies by 484.8% in the fourth quarter. True Wealth Design LLC now owns 462 shares of the medical device company’s stock valued at $38,000 after buying an additional 383 shares during the last quarter. Cromwell Holdings LLC raised its position in shares of Cooper Companies by 128.8% in the fourth quarter. Cromwell Holdings LLC now owns 485 shares of the medical device company’s stock valued at $40,000 after buying an additional 273 shares during the last quarter. Finally, Board of the Pension Protection Fund acquired a new position in shares of Cooper Companies in the fourth quarter valued at approximately $41,000. Institutional investors and hedge funds own 24.39% of the company’s stock.

Cooper Companies Stock Performance

NASDAQ COO opened at $62.55 on Tuesday. The Cooper Companies, Inc. has a 12 month low of $58.89 and a 12 month high of $89.83. The company has a debt-to-equity ratio of 0.22, a current ratio of 1.34 and a quick ratio of 0.79. The company has a market capitalization of $12.20 billion, a price-to-earnings ratio of 30.97, a price-to-earnings-growth ratio of 1.61 and a beta of 0.89. The company’s fifty day moving average price is $66.74 and its two-hundred day moving average price is $75.13.

Cooper Companies (NASDAQ:COO) last posted its quarterly earnings data on Thursday, March 5th. The medical device company reported $1.10 EPS for the quarter, beating analysts’ consensus estimates of $1.03 by $0.07. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.02 billion. Cooper Companies had a net margin of 9.67% and a return on equity of 10.34%. The firm’s revenue was up 6.2% compared to the same quarter last year. During the same period in the prior year, the firm posted $0.92 EPS. Cooper Companies has set its Q2 2026 guidance at 4.580-4.660 EPS. As a group, research analysts predict that The Cooper Companies, Inc. will post 4.62 earnings per share for the current fiscal year.

Wall Street Analyst Weigh In

COO has been the subject of several research analyst reports. Wall Street Zen raised shares of Cooper Companies from a “hold” rating to a “buy” rating in a research report on Saturday, February 28th. Rothschild & Co Redburn lowered shares of Cooper Companies from a “buy” rating to a “neutral” rating and set a $85.00 price target for the company. in a research report on Wednesday, March 4th. Barclays upped their price target on shares of Cooper Companies from $98.00 to $103.00 and gave the stock an “overweight” rating in a research report on Friday, March 6th. Citigroup dropped their price target on shares of Cooper Companies from $88.00 to $87.00 and set a “neutral” rating for the company in a research report on Friday, March 6th. Finally, William Blair raised shares of Cooper Companies to a “strong-buy” rating in a research report on Friday, January 30th. One equities research analyst has rated the stock with a Strong Buy rating, eight have given a Buy rating, seven have assigned a Hold rating and one has assigned a Sell rating to the company’s stock. Based on data from MarketBeat.com, the stock has an average rating of “Moderate Buy” and a consensus price target of $90.79.

Cooper Companies Company Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.